A novel multivalent tuberculosis vaccine confers protection in a mouse model of tuberculosis

Synthetic Consensus HIV-1 DNA Induces Potent Cellular Immune Responses and Synthesis of Granzyme B, Perforin in HIV Infected Individuals

(2015) Matthew P Morrow et al.   MOLECULAR THERAPY

Immune requirements for protective Th17 recall responses to Mycobacterium tuberculosis challenge

(2015) L Monin et al.   Mucosal Immunology

Molecular adjuvant IL-33 enhances the potency of a DNA vaccine in a lethal challenge model

(2015) Daniel O. Villarreal et al.   VACCINE

Alarmin IL-33 elicits potent TB-specific cell-mediated responses

(2015) Daniel O Villarreal et al.   Human Vaccines & Immunotherapeutics

Multifunctional, High-Level Cytokine-Producing Th1 Cells in the Lung, but Not Spleen, Correlate with Protection against Mycobacterium tuberculosis Aerosol Challenge in Mice

(2014) E. K. Forbes et al.   JOURNAL OF IMMUNOLOGY

Central Memory CD4+ T Cells Are Responsible for the Recombinant Bacillus Calmette-Guérin ΔureC::hly Vaccine's Superior Protection Against Tuberculosis

(2014) Alexis Vogelzang et al.   JOURNAL OF INFECTIOUS DISEASES

Multivalent TB vaccines targeting the esx gene family generate potent and broad cell-mediated immune responses superior to BCG

(2014) Daniel O Villarreal et al.   Human Vaccines & Immunotherapeutics

Interleukin-17-dependent CXCL13 mediates mucosal vaccine–induced immunity against tuberculosis

(2013) R Gopal et al.   Mucosal Immunology

Synthetic DNA Vaccines: Improved Vaccine Potency by Electroporation and Co-Delivered Genetic Adjuvants

(2013) Seleeke Flingai et al.   Frontiers in Immunology

Immunotherapy Against HPV16/18 Generates Potent TH1 and Cytotoxic Cellular Immune Responses

(2012) M. L. Bagarazzi et al.   Science Translational Medicine

H-2 alleles contribute to antigen 85-specific interferon-gamma responses during Mycobacterium tuberculosis infection

(2011) Gillian L. Beamer et al.   CELLULAR IMMUNOLOGY

IL-23-dependent IL-17 drives Th1-cell responses followingMycobacterium bovisBCG vaccination

(2011) Radha Gopal et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Recombinant BCG ΔureC hly+ Induces Superior Protection Over Parental BCG by Stimulating a Balanced Combination of Type 1 and Type 17 Cytokine Responses

(2011) Christiane Desel et al.   JOURNAL OF INFECTIOUS DISEASES

Early Secreted Antigen ESAT-6 of Mycobacterium tuberculosis Promotes Protective T Helper 17 Cell Responses in a Toll-Like Receptor-2-dependent Manner

(2011) Samit Chatterjee et al.   PLoS Pathogens

Screening of Predicted Secreted Antigens from Mycobacterium bovis Reveals the Immunodominance of the ESAT-6 Protein Family

(2010) G. J. Jones et al.   INFECTION AND IMMUNITY

Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 Signaling

(2009) Yeonseok Chung et al.   IMMUNITY

ESAT-6 Inhibits Production of IFN-  by Mycobacterium tuberculosis-Responsive Human T Cells

(2009) X. Wang et al.   JOURNAL OF IMMUNOLOGY